Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. We aim to create futures for patients, their families and our employees. Learn more about our mission, discover our “Whole You” benefits package and search for your next career opportunity: https://www.formatherapeutics.com/careers/ Read our community guidelines: https://www.formatherapeutics.com/community-guidelines/